300791 仙乐健康
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)6.54311.0398.0939.80812.470
总资产报酬率 ROA (%)2.9825.9915.3037.16710.277
投入资产回报率 ROIC (%)3.5577.0115.9418.08511.880

边际利润分析
销售毛利率 (%)32.04530.26531.17832.72432.601
营业利润率 (%)8.6827.87310.57212.23415.270
息税前利润/营业总收入 (%)10.3849.08910.31812.97015.248
净利润/营业总收入 (%)6.8286.7088.4679.78612.452

收益指标分析
经营活动净收益/利润总额(%)98.24998.97397.16691.77188.720
价值变动净收益/利润总额(%)-0.675-20.2938.6508.5956.447
营业外收支净额/利润总额(%)-2.752-3.209-5.382-3.173-1.169

偿债能力分析
流动比率 (X)2.4882.5735.1795.7593.420
速动比率 (X)1.7621.9334.6845.0382.731
资产负债率 (%)51.79250.61035.46033.3850.176
带息债务/全部投入资本 (%)27.38525.64423.84623.8260.552
股东权益/带息债务 (%)195.463215.257307.274308.71417,364.350
股东权益/负债合计 (%)87.16290.891182.007199.539467.435
利息保障倍数 (X)5.3696.22336.08011.66198.716

营运能力分析
应收账款周转天数 (天)57.74853.89757.54545.83139.029
存货周转天数 (天)68.30451.42549.25657.19260.871